2022 annual financial data
Citius Oncology 2022 Operating margin
Citius Oncology 2022 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -9,713,198 USD and net income was -10,865,198 USD.
Operating cash flow was -47,968 USD.
Get free Citius Oncology email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -9,713,198 USD
- Net income
- -10,865,198 USD
- Operating cash flow
- -47,968 USD